Immunotherapy of angiogenesis with DNA vaccines

Chien Fu Hung, Archana Monie, T. C. Wu

Research output: Chapter in Book/Report/Conference proceedingChapter


The understanding of the molecular mechanisms of tumor neovascularization has identified several important molecular targets that are specifically expressed on tumor neovasculature but not on physiological neovasculature. These molecular targets can potentially be used in the development of novel therapeutic approaches against tumor angiogenesis. Immunotherapy targeting angiogenesis has emerged as a potentially promising approach compared to the use of angiogenesis inhibitors due to its ability to afford long-term therapeutic protection. This presents remarkable opportunities for the development of innovative cancer therapies.Immunotherapy using DNA vaccines has gained momentum for antiangiogenesis therapy due to their stability, simplicity and excellent safety profile, and may prove to be a potentially useful strategy for targeting angiogenesis. In the current review, we discuss the various strategies and molecular targets employed in the form of DNA vaccines to target: (1) the endothelial cells within the tumor; (2) biological factors important for angiogenesis; and (3) the extracellular matrix and stromal cells associated with the tumor in order to control tumor angiogenesis in preclinical models.

Original languageEnglish (US)
Title of host publicationAngiogenesis
Subtitle of host publicationAn Integrative Approach From Science to Medicine
PublisherSpringer US
Number of pages10
ISBN (Print)9780387715179
StatePublished - Dec 1 2008


  • DNA vaccines
  • angiogenesis
  • endothelial cells
  • immunotherapy

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Immunotherapy of angiogenesis with DNA vaccines'. Together they form a unique fingerprint.

Cite this